Free Padua Score Calculator

The Padua Score: A Clinical VTE Risk Assessment Tool

The Padua Score is a widely used venous thromboembolism (VTE) risk calculator that helps clinicians determine whether hospitalized medical patients require pharmacological prophylaxis. By systematically evaluating 11 distinct risk factors, the Padua Prediction Score provides a quantifiable measure of thromboembolism risk. This guide explains how the score is calculated, how to interpret the results, and where it fits within the broader VTE prophylaxis assessment process.

Understanding Venous Thromboembolism

Venous thromboembolism is a disease spectrum originating from abnormal clot formation in the veins. The underlying mechanism is often described by Virchow’s triad: venous stasis, endothelial injury, and hypercoagulability. VTE most commonly presents as deep vein thrombosis (DVT), characterized by swelling, warmth, and pain in an extremity. If the thrombus dislodges and migrates, it becomes an embolus capable of causing pulmonary embolism (PE), a potentially life‑threatening blockage of pulmonary arteries. Less frequent but clinically important presentations include cerebral venous sinus thrombosis (CVST), often seen in pregnancy and postpartum, and Budd‑Chiari syndrome, which involves thrombosis of the hepatic veins and can lead to liver insufficiency. In patients with cardiac structural defects (such as an atrial septal defect), a paradoxical embolism may occur, where the clot crosses into the systemic circulation and causes an ischemic stroke.

Why Formal Risk Assessment Matters

Hospitalized patients, especially those with acute medical illnesses, face an elevated risk of VTE. Prophylactic anticoagulation reduces this risk but must be weighed against the potential for bleeding. Standardized risk scores like the Padua VTE score provide an objective framework for this decision. They complement clinical judgment by identifying individuals who are most likely to benefit from pharmacologic prevention.

The diagnostic workup for suspected VTE typically begins with less invasive tests: measurement of D‑dimer levels and clinical evaluation for DVT signs. Compression ultrasonography can confirm a thrombus when present. In acute, life‑threatening situations—marked by signs of cardiopulmonary insufficiency—imaging such as CT or CT angiography should be performed without delay to direct rapid treatment.

Alongside the Padua score, other validated risk assessment models exist. For pulmonary embolism, the Revised Geneva and Wells scores are commonly applied; both consider age, clinical signs of DVT, immobilization, and comorbid conditions. In surgical populations, the Caprini score is often the tool of choice. The Padua score, however, was developed specifically for medical inpatients and is incorporated into many institutional thrombosis prophylaxis guidelines. Coagulation status and bleeding risk can be further assessed with PT/INR tests, the HAS‑BLED score, or CHA₂DS₂‑VASc stratification, where appropriate.

Calculating the Padua Prediction Score

The Padua Score is the sum of points assigned for 11 clinical variables. Each variable carries a weight of 0, 1, 2, or 3 points depending on its contribution to VTE risk.

Risk Factor	Points if Present	Points if Absent
Age ≥ 70 years	1	0
Obesity (BMI ≥ 30 $\text{kg/m}^2$)	1	0
Reduced mobility (expected bed rest ≥ 3 days)	3	0
Hormonal treatment (contraceptives or replacement therapy)	1	0
Active cancer (under treatment or diagnosed within 6 months)	3	0
Recent trauma or surgery (within 1 month)	2	0
Previous VTE (history of DVT or PE)	3	0
Known thrombophilic condition (e.g., factor V Leiden, prothrombin mutation)	3	0
Heart or respiratory failure	1	0
Acute myocardial infarction or ischemic stroke	1	0
Acute infection or rheumatologic disease	1	0

The total score is obtained by adding the points for all applicable factors:

$$\text{Padua Score} = \sum_{i=1}^{11} \text{points}_i$$

Interpreting the Score and Guiding Prophylaxis

A total Padua Score of 4 or higher identifies the patient as being at high risk for VTE. In such patients, pharmacological prophylaxis (e.g., low‑molecular‑weight heparin or unfractionated heparin) is generally recommended unless contraindications exist. A score below 4 indicates low risk, and mechanical prophylaxis or early mobilization may be sufficient.

Prophylaxis Modalities

VTE prophylaxis can be delivered through mechanical and pharmacological means, and they are often used concurrently.

• Mechanical methods: Graduated compression stockings, intermittent pneumatic compression devices, early ambulation, and calf exercises.
• Pharmacological methods: Anticoagulants including low‑molecular‑weight heparin (LMWH), unfractionated heparin (UFH), vitamin K antagonists (e.g., warfarin), and direct oral anticoagulants (DOACs).

The choice of regimen depends on the patient’s risk profile, bleeding risk, renal function, and clinical context.

Clinical Limitations and Responsible Use

While the Padua VTE Risk Calculator is a valuable decision support tool, it is not a substitute for clinical reasoning. The score does not capture every potential risk factor (e.g., central venous catheters, prolonged travel), and its predictive performance may vary across different populations. Always interpret the result alongside the patient’s full clinical picture, consult up‑to‑date evidence‑based guidelines, and cross‑reference with institutional protocols. The calculator should augment, not replace, the clinician’s own risk‑benefit assessment.